Your browser doesn't support javascript.
loading
MANAGEMENT OF ENDOCRINE DISEASE: Residual adrenal function in Addison's disease.
Pearce, Simon H S; Gan, Earn H; Napier, Catherine.
Afiliação
  • Pearce SHS; Translational and Clinical Research Institute, Newcastle University, Newcastle, UK.
  • Gan EH; Endocrine Unit, Royal Victoria Infirmary, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle, UK.
  • Napier C; Translational and Clinical Research Institute, Newcastle University, Newcastle, UK.
Eur J Endocrinol ; 184(2): R61-R67, 2021 Feb.
Article em En | MEDLINE | ID: mdl-33306039
ABSTRACT
Over the last 10 years, evidence has accumulated that autoimmune Addison's disease (AAD) is a heterogeneous disease. Residual adrenal function, characterised by persistent secretion of cortisol, other glucocorticoids and mineralocorticoids is present in around 30% of patients with established AAD, and appears commoner in men. This persistent steroidogenesis is present in some patients with AAD for more than 20 years, but it is commoner in people with shorter disease duration. The clinical significance of residual adrenal function is not fully clear at the moment, but as it signifies an intact adrenocortical stem cell population, it opens up the possibility of regeneration of adrenal steroidogenesis and improvement in adrenal failure for some patients.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Addison / Glândulas Suprarrenais / Doenças do Sistema Endócrino Limite: Female / Humans / Male Idioma: En Revista: Eur J Endocrinol Assunto da revista: ENDOCRINOLOGIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Addison / Glândulas Suprarrenais / Doenças do Sistema Endócrino Limite: Female / Humans / Male Idioma: En Revista: Eur J Endocrinol Assunto da revista: ENDOCRINOLOGIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Reino Unido